SeromYx Systems provides high throughput assays that characterize antigen-specific antibody effector functions, supported by a machine learning computational biology platform, collectively Systems Serology. Systems Serology can be used throughout the drug discovery and development process:
– To establish immune markers of disease, progression, or protection and resolution;
- To screen large panels of monoclonal antibodies for desired function;
- To support pre-clinical and IND-enabling measurement of induced response or in vitro mAb effector activity;
- To measure clinical response, biomarkers of activity or progression or in vivo mAb function;
- To support filings for marketing approval with surrogate endpoints and support for comparability in CMC filings.

Each project is customized in terms of assay and antigen selection and computational approach, if any, to meet client needs.

SeromYx is certified as compliant with GCLP, and performs studies in compliance with that standard.